The Manchester VA Medical Center is a medical facility for US military veterans located in Manchester, New Hampshire. It is part of the VA New England Healthcare System, and operates under the Department of Veterans Affairs to provide healthcare to veterans who are residents of New Hampshire.

There are 90 beds in Manchester VA Medical Center.

During the past decade, Manchester VA Medical Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Manchester VA Medical Center" #1 sponsor was "VA Office of Research and Development" with 5 trials, followed by "INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium" with 2 trials sponsored, "Celgene" with 1 trials sponsored, "VA Boston Healthcare System" with 1 trials sponsored and "Yale University" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Manchester VA Medical Center" #1 collaborator was "U.S. Army Medical Research and Development Command" with 2 trials as a collaborator, "US Department of Veterans Affairs" with 2 trials as a collaborator, "National Center for Complementary and Integrative Health (NCCIH)" with 1 trials as a collaborator and "National Institute on Drug Abuse (NIDA)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Manchester VA Medical Center" are "Hypertension" (2 trials), "Brain Injuries, Traumatic" (1 trials), "Colorectal Cancer" (1 trials), "Insomnia Disorder" (1 trials) and "Leukemia, Myeloid, Acute" (1 trials). Many other conditions were trialed in "Manchester VA Medical Center" in a lesser frequency.

Most popular intervention types in "Manchester VA Medical Center" are "Drug" (3 trials), "Behavioral" (2 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "ATHENA-CDS-HTN plus Guideline Link" (1 trials), "Chlorthalidone" (1 trials), "Colonoscopy" (1 trials), "FIT" (1 trials) and "Galantamine 12 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Manchester VA Medical Center" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Manchester VA Medical Center". 1 are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Manchester VA Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Manchester VA Medical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".